Playback speed
10 seconds
ESMO 2022 on the Phase 4 KEYNOTE-B10 Study: Pembro + Carbo + Paclitaxel as 1L Therapy in Recurrent/Metastatic HNSCC
By
ESMO 2022 Conference Coverage
FEATURING
Marcin Dzienis
By
ESMO 2022 Conference Coverage
FEATURING
Marcin Dzienis
55 views
September 30, 2022
Login to view comments.
Click here to Login